We are live on ! Find out more
CEROW

CERo Therapeutics Warrants
CEROW

Delisted

CEROW was delisted on the 30th of October, 2025.

Back to rankings

37 hedge funds and large institutions have $425K invested in CERo Therapeutics Warrants in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

124% more capital invested

Capital invested by funds: $190K → $425K (+$235K)

8% less funds holding

Funds holding: 40 → 37 (-3)

25% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 8

56% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 9

Holders
37
Holders Change
-3
Holders Change %
-7.5%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
9
Closed
8
Calls
$7K
Puts
–
Net Calls
+$7K
Net Calls Change
+$4K

Top Buyers

Rank Fund Capital Flow
1
CAC
Cowen and Company
New York
+$26.7K
2
ACM
Atalaya Capital Management
New York
+$12.2K
3
ICM
Ionic Capital Management
New York
+$4.88K
4
CF
Cantor Fitzgerald
New York
+$4.71K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$848

Top Sellers

Rank Fund Capital Flow
1
SCM
Segantii Capital Management
Hong Kong
-$55K
2
PC
Periscope Capital
Ontario, Canada
-$22.2K
3
PAMP
Polar Asset Management Partners
Ontario, Canada
-$8.25K
4
AA
AQR Arbitrage
Connecticut
-$5.8K
5
CCM
Context Capital Management
California
-$4.74K
Name Holding Trade Value Shares
Change 		Change in
Stake
HCM
1
Highbridge Capital Management
New York
$73.7K – – –
CAC
2
Cowen and Company
New York
$43.6K +$26.7K +438,511 +219%
PC
3
Periscope Capital
Ontario, Canada
$40.3K -$22.2K -365,598 -38%
ACM
4
Atalaya Capital Management
New York
$37.8K +$12.2K +200,000 +89%
CF
5
Cantor Fitzgerald
New York
$35.2K +$4.71K +77,500 +21%
SCM
6
Saba Capital Management
New York
$26.3K – – –
MI
7
MMCAP International
Cayman Islands
$25.6K – – –
LA
8
Linden Advisors
New York
$20K – – –
CSD
9
Clear Street Derivatives
New York
$18.3K +$16.3K +268,129 New
SCM
10
Shaolin Capital Management
Florida
$18.3K -$1.42K -23,400 -8%
QGA
11
Q Global Advisors
Texas
$12K – – –
CS
12
Clear Street
New York
$9.82K +$175 +2,883 +2%
CCM
13
Context Capital Management
California
$8.32K -$4.74K -77,987 -39%
NAM
14
Nexpoint Asset Management
Texas
$7.42K – – –
WCMNY
15
Westchester Capital Management (New York)
New York
$6.67K – – –
ICM
16
Ionic Capital Management
New York
$5.48K +$4.88K +80,300 New
PMAM
17
Picton Mahoney Asset Management
Ontario, Canada
$5K – – –
WAM
18
Wolverine Asset Management
Illinois
$4.37K -$1.45K -23,780 -27%
KL
19
KIM LLC
Kansas
$3.41K – – –
TCM
20
Tenor Capital Management
New York
$3.41K – – –
YCM
21
Yakira Capital Management
Connecticut
$3.41K – – –
HF
22
HRT Financial
New York
$3K -$18 -296 -0.8%
RCM
23
Rivernorth Capital Management
Florida
$1.75K – – –
WA
24
Whitebox Advisors
Minnesota
$1.71K – – –
Walleye Capital
25
Walleye Capital
New York
$1.64K -$125 -2,050 -8%
1
2

CEROW Hedge Fund Activity: Q1 2024 in Review

37 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics Warrants (CEROW) for Q1 2024, worth a combined $425K — up 124% from $190K a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of CEROW and 6 opened new positions — a net loss of 2 holders — while 9 trimmed existing stakes and 4 added.

The largest buyer was Cowen and Company, adding an estimated $26.7K. The largest seller was Segantii Capital Management, exiting entirely with an estimated $55K sold.

  • 37 institutional investors held CERo Therapeutics Warrants (CEROW) as of Q1 2024, down from 40 in Q4 2023.
  • Funds reported $425K of CERo Therapeutics Warrants stock for Q1 2024, up 124% quarter-over-quarter.
  • 6 funds opened new CERo Therapeutics Warrants positions in Q1 2024 and 8 closed out, a net change of -2 holders.
  • The largest CERo Therapeutics Warrants buyer in Q1 2024 was Cowen and Company, an estimated $26.7K added.
  • The largest CERo Therapeutics Warrants seller in Q1 2024 was Segantii Capital Management, an estimated $55K sold.

Based on aggregated 13F filings for Q1 2024.